These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7699664)

  • 1. The eosinophilia-myalgia syndrome--guidelines for patient care.
    Hertzman PA; Kaufman LD; Love LA; Mease PJ; Philen RM; Pincus T; Rosenberg NL; Silver R; Varga J; Clauw DJ
    J Rheumatol; 1995 Jan; 22(1):161-3. PubMed ID: 7699664
    [No Abstract]   [Full Text] [Related]  

  • 2. The toxic oil syndrome and the eosinophilia-myalgia syndrome: pursuing clinical parallels.
    Hertzman PA; Borda IA
    J Rheumatol; 1993 Oct; 20(10):1707-10. PubMed ID: 8295182
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of the eosinophilia-myalgia syndrome.
    Silver RM
    J Rheumatol Suppl; 1996 Oct; 46():26-36. PubMed ID: 8895179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
    André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
    Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
    Sidransky H
    Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demyelinating nervous lesions in myalgia-eosinophilia syndrome induced by L Tryptophan].
    Labauge P; Moulonguet A; Penaud D; Lessana-Leibowitch M; Kahn MF; Said G
    Rev Neurol (Paris); 1993; 149(4):278-82. PubMed ID: 8235226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A lesson on the purity of pharmaceutical products derived from biotechnology: eosinophilia-myalgia syndrome].
    Boll Chim Farm; 1995; 134(7):394-5. PubMed ID: 7546544
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case report.
    Smith E; Gordon M; Lebwohl M
    Cutis; 2006 Jun; 77(6):361-4. PubMed ID: 16838769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia.
    Margolin L
    J Rheumatol; 2003 Mar; 30(3):628-9. PubMed ID: 12610828
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuromuscular diseases with eosinophilia].
    Pellissier JF; Figarella-Branger D; Serratrice G
    Med Trop (Mars); 1998; 58(4 Suppl):471-6. PubMed ID: 10410368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
    Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan.
    Mizutani T; Mizutani H; Hashimoto K; Nakamura Y; Kishida M; Taniguchi H; Murata M; Kuzuhara S; Shimizu M
    J Am Acad Dermatol; 1991 Sep; 25(3):512-7. PubMed ID: 1918490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilia-myalgia syndrome in a child with phenylketonuria.
    Springer MA; Bock HG; Philen RM; Hill RH; Crawford LV
    Pediatrics; 1992 Oct; 90(4):630-3. PubMed ID: 1408523
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome.
    Hudson JI; Pope HG; Carter WP; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():37-42; discussion 42-3. PubMed ID: 8895180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The eosinophilia-myalgia syndrome and tryptophan.
    Belongia EA; Mayeno AN; Osterholm MT
    Annu Rev Nutr; 1992; 12():235-56. PubMed ID: 1503805
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophilia-myalgia syndrome: the Cleveland Clinic experience.
    Thacker HL
    Cleve Clin J Med; 1991; 58(5):400-8. PubMed ID: 1934454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
    Cilursu AM; Goeken J; Olson RR
    Ann Rheum Dis; 1991 Nov; 50(11):817-9. PubMed ID: 1772299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
    de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
    Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilia-myalgia syndrome and giant cell myocarditis: a case report and therapeutic approach.
    Amidon TM; Baldwin JL; George E
    Heart Dis; 1999; 1(2):66-7. PubMed ID: 11720607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The eosinophilia-myalgia syndrome: what we know, what we think we know, and what we need to know.
    Clauw DJ; Pincus T
    J Rheumatol Suppl; 1996 Oct; 46():2-6. PubMed ID: 8895175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.